GlaxoSmithKline VP of Finance Salaries in Boulder | Comparably
"GlaxoSmithKline discovers, develops and manufactures pharmaceuticals, vaccines and consumer healthcare products." read more
EMPLOYEE
PARTICIPANTS
39
TOTAL
RATINGS
383

GlaxoSmithKline VP of Finance Salaries in Boulder

The average GlaxoSmithKline VP of Finance in Boulder earns an estimated $150,655 annually. GlaxoSmithKline's VP of Finance compensation is $55,875 less than the US average for a VP of Finance.

In Boulder, The Finance Department at GlaxoSmithKline earns $6,369 more on average than the Operations Department.

Last updated 2 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$150,655
Average Compensation
$150,655
avg. base

VP of Finance Salaries at GlaxoSmithKline

In Boulder, VPs of Finance earn $55,842 more than Accounting Managers.

Accounting Manager
$95k*
Senior Accountant
$94k*
Business Analyst
$82k*
Financial Analyst
$76k*
Accountant
$69k*
* estimated salary

Compensation at GlaxoSmithKline by Department

In Boulder, The Finance Department averages $6,369 more than the Operations Department, and $13,811 less than the Sales Department

Sales
$91,628 Avg. total comp.
+$14k
Finance
$77,817 Avg. total comp.
Operations
$71,448 Avg. total comp.
-$6k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to GlaxoSmithKline reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to GlaxoSmithKline reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at GlaxoSmithKline Rate Their Compensation

The majority of VPs of Finance at GlaxoSmithKline believe they're compensated fairly. 100% of VPs of Finance at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline

×
Rate your company